author-photo

Silvia Chang

20

Papers

154

Citations

Citation Trend

Filter By

Papers (15) Sort By

Journal Conference Others

Three-year study of pre-existing drug resistance substitutions and efficacy of bictegravir/emtricitabine/tenofovir alafenamide in HIV-1 treatment-naive participants.

2021 Journal of Antimicrobial Chemotherapy
Show All
- Source
- Cite
- Save
Citations (1)
Remdesivir targets a structurally analogous region of the Ebola virus and SARS-CoV-2 polymerases.

2020 Proceedings of the National Academy of Sciences of the United States of America
Show All
- Source
- Cite
- Save
Citations (35)
633. Bictegravir/Emtricitabine/Tenofovir Alafenamide (B/F/TAF) Efficacy in Participants with Pre-Existing Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials

2020 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
109. Preexisting Resistance and Week 48 Virologic Outcomes After Switching to B/F/TAF in African American Adults with HIV

2020 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (0)
Simulating HIV Breakthrough and Resistance Development During Variable Adherence to Antiretroviral Treatment.

2020 Journal of Acquired Immune Deficiency Syndromes
Show All
- Source
- Cite
- Save
Citations (1)
Characterization of Hepatitis B virus polymerase mutations A194T and CYEI and tenofovir disoproxil fumarate or tenofovir alafenamide resistance.

2020 Journal of Viral Hepatitis
Show All
- Source
- Cite
- Save
Citations (2)
SAT-168-HBV splice DNA forms detected in serum in majority of patients with chronic HBV infection

2019 Journal of Hepatology
Show All
- Source
- Cite
- Save
Citations (0)
Identification of 19 Novel Hepatitis C Virus Subtypes—Further Expanding HCV Classification

2019 Open Forum Infectious Diseases
Show All
- Source
- Cite
- Save
Citations (38)
Erratum to: Switching to bictegravir/emtricitabine/tenofovir alafenamide maintained HIV-1 RNA suppression in participants with archived antiretroviral resistance including M184V/I

2019 Journal of Antimicrobial Chemotherapy
Show All
- Source
- Cite
- Save
Citations (17)
Resistance Analysis of Bictegravir-Emtricitabine-Tenofovir Alafenamide in HIV-1 Treatment-Naive Patients through 48 Weeks

2019 Antimicrobial Agents and Chemotherapy
Show All
- Source
- Cite
- Save
Citations (14)